EDITORIAL: Pharma can be a PR health hazard

We've seen no shortage of apologies in the past few months from

corporations, politicians and the like, but last week, it was the turn

of a PR agency to say it was sorry. The Toronto office of

Fleishman-Hillard apologized to Bristol-Myers Squibb after an e-mail,

which accompanied a press release, was found to have overhyped the

benefits of heart drug Clopidogrel, claiming that it was the biggest

thing to have hit the anti-blood clotting world since the aspirin. (See

story, p. 5.) It was not enough to prevent the pharma giant from firing

Fleishman, but the agency hopes that in the meantime, it has put its

house in order, with local GM Linda Smith now insisting that e-mails, as

well as releases, must be checked prior to delivery.



This story underlines the treacherous waters into which PR wades when it

promotes medical products. Fleishman says the hype was just a mistake,

but it seems more likely that this was an overenthusiastic espousal of a

product by an account executive who was keen to get results for the

client, and hoped that a tantalizing little sound bite would provide a

bait to journalists.



Almost everyone in PR is guilty of exaggeration on occasion, and most

journalists understand that (indeed they're guilty themselves), but the

critical, often life-threatening nature of healthcare products makes it

vitally important that PR does not overstep the boundaries. The

importance of healthcare PR in this current environment also makes it

crucial that PR is not drawn further into the growing debate on

advertising new drugs directly to consumers.



The role of e-mail in PR But there's a second issue that the

Fleishman-Hillard/Bristol-Myers Squibb incident raises, and that's the

role of e-mail in PR. PR firms are not only control freaks by nature,

they're also accountable, and so it's natural that when an incident such

as this occurs, it encourages them to put more and more draconian

measures in place to ensure it "doesn't happen again." But as many an

account executive will tell you, today's press releases can go through a

committee process that eliminates all punch, personality, and in some

cases, grammar and English. The e-mail, then, becomes the only

opportunity to deal with reporters at a one-to-one level, allowing the

AEs to inject those little personal touches that can be the difference

between the bin and the building of a decent relationship with the

journalist.



If Fleishman insists on checking all e-mails before they can be sent out

- and as PRWeek went to press it was not clear if this was a

company-wide directive, or in healthcare PR divisions, or in the Toronto

office only - it risks stifling the last few strands of personal

freedom, trust and empowerment that employees have in their media

relations. For the client, that might seem like a relief, but it could

also be to the client's ultimate disservice.



The best service to the client, in our opinion, is to train employees to

understand the importance of accuracy above all things. Making casual

statements in e-mails to reporters can be good media relations practice.

But not if it's hype, and certainly not if it's inaccurate.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.